Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
38 studies found for:    " October 06, 2010":" November 05, 2010"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
21 Active, not recruiting
Has Results
A Study of GSK1349572 Versus Raltegravir (RAL) With Investigator Selected Background Regimen in Antiretroviral-Experienced, Integrase Inhibitor-Naive Adults
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: GSK1349572;   Drug: Raltegravir;   Drug: GSK1349572 Placebo;   Drug: Raltegravir Placebo
22 Completed Phase 1, Open Label, Two Arm, Fixed Sequence Study to Evaluate the Effect of Rifampin and Rifabutin on GSK1349572 Pharmacokinetics in Healthy Male and Female Volunteers
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: GSK1349572;   Drug: Rifampin;   Drug: Rifabutin
23 Completed Acceptability Study of Vaginal Films for HIV Prevention
Conditions: HIV Infections;   Anti-Infective Agents
Intervention: Other: No intervention (not applicable)
24 Completed Epidemiology of Papillomavirus Infection (HPV) on Infected Women by Human Immunodeficience Virus (HIV) in West Indies and French Guiana.
Conditions: 1- Women;   2- HIV Infection;   3- Followed in West Indies and French Guiana for His Infection;   4- Acceptance of the Use of Nadis® Medical Files
Intervention: Other: Biological Sample collection
25 Recruiting Reducing Heavy Drinking to Optimize HIV/AIDS Treatment and Prevention
Condition: Reduction in Heavy Drinking in Patients With HIV
Interventions: Drug: Naltrexone;   Other: Placebo + Medication Management/Medication Coaching
26 Unknown  Effect of Maraviroc (MCV) on the Immunological Recovery of HIV-1 Discordant Patients With CD4 Lymphocyte Counts Below 200 Cells/mm3
Condition: HIV-1 Infection
Intervention: Drug: Maraviroc
27 Active, not recruiting Effects of Cash Transfer for the Prevention of HIV in Young South African Women
Condition: HIV
Interventions: Behavioral: monthly cash transfer payments for attending school;   Behavioral: B--No cash transfers
28 Unknown  Safety Study of Raltegravir in HIV/HCV Co-infected Patients
Conditions: HIV;   Hepatitis C
Interventions: Drug: raltegravir;   Drug: Atazanavir/ritonavir
29 Completed Study on Long Term Outcomes of Atazanavir in Antiretroviral-naïve Human Immunodeficiency Virus (HIV) Patients in Real Life Setting
Condition: HIV
Intervention:
30 Completed
Has Results
Effects of Famotidine on the Pharmacokinetics of Atazanavir When Coadministered to Participants With HIV Infection
Condition: HIV
Interventions: Drug: Atazanavir;   Drug: Ritonavir;   Drug: Tenofovir (TDF);   Drug: Nucleoside Reverse Transcriptase Inhibitor (NRTI);   Drug: Famotidine (FAM)
31 Recruiting Hydroxychloroquine for Discordant CD4 Responders on Highly Active Antiretroviral Therapy (HAART)
Condition: HIV Infection
Intervention: Drug: Hydroxychloroquine
32 Completed Efficacy and Safety of GSK Biologicals HIV Vaccine in Antiretroviral Therapy (ART)-naïve HIV-1 Infected Persons
Condition: AIDS
Interventions: Biological: GSK Biologicals HIV Vaccine 732462;   Drug: Placebo
33 Completed
Has Results
Gentian Violet Vs. Nystatin Oral Suspension for Treatment of Oropharyngeal Candidiasis
Condition: HIV-1 Infection
Interventions: Drug: Gentian Violet;   Drug: Nystatin oral suspension
34 Unknown  Preventing Health Damaging Behaviors in Male and Female Army Recruits
Conditions: Sexually Transmitted Infection (STI) Prevention;   Unintended Pregnancy Prevention;   Sexual Risk Reduction;   Alcohol and Other Substance Use Prevention;   Intimate Partner Violence Prevention
Intervention: Behavioral: Staying Safe & In Control: Increasing Knowledge and Building Skills to Prevent STIs and Unintended Pregnancy
35 Completed Estimate The Effect Of Lersivirine On The Pharmacokinetics Of Abacavir/Lamivudine In Healthy Subjects
Condition: Healthy Volunteers
Interventions: Drug: Abacavir/Lamivudine;   Drug: Lersivirine
36 Completed Safety And Tolerability Of Multiple Dose Lersivirine For 21 Days In Healthy Subjects
Condition: Healthy Volunteers
Intervention: Drug: Lersivirine
37 Unknown  Third Line Highly Active Antiretroviral Therapy (HAART) in HIV-infected Children
Condition: This Study is Designed to Collect Treatment Data of Thai Children on Third Line ARV Therapy.
Intervention:
38 Completed Family Planning Through Dairy Cooperatives
Conditions: The Study Goal is to Assess the Introduction of Sustainable Family Planning/Reproductive Health Information and Services Through;   Land O' Lakes-supported Dairy Cooperatives
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-38) Next Page   
Indicates status has not been verified in more than two years